Avance Life Sciences UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 1,000 |
| 20 |
| 0 |
| 1,020 |
| 2024 |
|---|
| 59,000 |
| 29,500 |
| 993 |
| 830 |
| 415 |
| 100.00 |
| 1.41 |
| 1,830 |
| 1,157 |
| 0 |
| 2,987 |
| 2025 |
|---|
| 3,000 |
| 1,500 |
| -2,572 |
| -2,572 |
| -1,286 |
| 100.00 |
| -85.73 |
| -805 |
| 1,123 |
| 0 |
| 318 |
Register and
explore Okredo data| 2025 |
|---|
| 3,000 |
| 1,500 |
| -2,572 |
| -2,572 |
| -1,286 |
| 100.00 |
| -85.73 |
| -805 |
| 1,123 |
| 0 |
| 318 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
3,000 €-95 % *
Sales per employee (€)
1,500 €-95 % *
Profit before tax (€)
-2,572 €-359 % *
Net Profit (€)
-2,572 €-410 % *
Profit per employee (€)
-1,286 €-410 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-85.73 %-6,180.14 % *
Equity (€)
-805 €-144 % *
Amounts Payable And Liabilities (€)
1,123 €-3 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
318 €-89 % *
